{"id":"W3129156895","doi":"10.1161/jaha.120.019238","title":"Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM‐HF","year":2021,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Université de Montréal; Montreal Heart Institute","funders":"Relypsa; Regeneron Pharmaceuticals; National Institutes of Health; MyoKardia; Novo Nordisk; Daiichi Sankyo Europe; Gilead Sciences; Servier; University of Glasgow; British Heart Foundation; Cytokinetics; Ironwood Pharmaceuticals, Incorporated; National Heart, Lung, and Blood Institute; Sun Pharma; Defense Acquisition Program Administration; Boston Scientific Corporation; Alnylam Pharmaceuticals; Sanofi; GlaxoSmithKline; Celladon Corporation; Amgen; Vifor Pharma; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Ejection fraction; COPD; Heart failure; Internal medicine; Cardiology; Hazard ratio; Enalapril; Valsartan; Natriuretic peptide; Heart failure with preserved ejection fraction; Angiotensin-converting enzyme; Confidence interval; Blood pressure","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007506293,0.0002319202,0.0002892761,0.0004613683,0.0001477819,0.000296729,0.0002795908,0.000428631,0.0007919722],"category_scores_gemma":[0.001335606,0.00009484568,0.0004908455,0.0004399287,0.0001568182,0.0003100617,0.0003711876,0.0003888445,0.0001108515],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002119211,"about_ca_system_score_gemma":0.0002193201,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001384673,"about_ca_topic_score_gemma":0.001796513,"domain_scores_codex":[0.9997137,0.0001038691,0.0000289271,0.00006329629,0.00004254877,0.0000475601],"domain_scores_gemma":[0.9992536,0.000166849,0.0003093794,0.00003796896,0.00006370556,0.0001684629],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003972286,0.0000735805,0.996232,0.0000183109,0.0001322317,0.00005454351,0.0000272298,0.00008656584,0.0001548848,0.00003610477,0.0002325179,0.002554919],"study_design_scores_gemma":[0.00004208222,0.0001462326,0.9989826,0.000008235618,0.00005341658,0.0001792429,0.00005084156,0.0002777988,0.00002379667,0.00007436051,0.0001583552,0.000002956857],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981374,0.0006950251,0.00007633216,0.0001698651,0.000009104794,0.000006747125,0.0005598351,0.000001174944,0.000344452],"genre_scores_gemma":[0.9986039,0.0002094817,0.00009625079,0.00009022845,0.00004656089,0.00001093455,0.0008861785,7.51402e-7,0.00005569475],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001384673,"threshold_uncertainty_score":0.003969789,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008678459535362894,"score_gpt":0.2691748798920032,"score_spread":0.2604964203566403,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}